Registered entities
Orionis Biosciences Inc.
Reg. No. 47-4282900United States
Orionis Biosciences Bv
Reg. No. 0635.962.088Belgium
Innovation
41 patent families (19 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing; filing pace slowing. Cited 9,917 times.
| Year | Filings |
|---|---|
| 2017 | 4 |
| 2018 | 5 |
| 2019 | 13 |
| 2020 | 18 |
| 2021 | 28 |
| 2022 | 25 |
| 2023 | 23 |
| 2024 | 20 |
| 2025 | 19 |
| 2026 | 12 |
Social engagement
Social engagement: 5.3K social following, 2 posts in the last 12 months — below the industry typical range.
Investor mix
8 investors on record; lead investors include V-Bio Ventures, Excel Venture Management, Novartis, Cormorant Asset Management.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 6 | 75% |
| Angel & family office | 1 | 13% |
| Other / undisclosed | 1 | 13% |
Recent activity
10 Jun 2026
Partnership
Novartis
1 Apr 2026
Leadership hire
Chief Strategy Officer